MoneyWorks4Me

Omkar Speciality Chemicals files Patent application for precursor of latest Hepatitis C Drug

03 Jun 2015 Evaluate

Omkar Speciality Chemicals has filed one more application for the grant of Patent for preparing 4-Bromo-Ortho-Phenylene-Diamine, a key precursor for making of the drug namely Ledipasvir. Ledipasvir is a drug for the treatment of Hepatitis C.

Omkar Speciality Chemicals (including its wholly owned subsidiaries) has 9 Units in the State of Maharashtra, India (5 Units in Badlapur, Dist: Thane, 3 Units in Chiplun, Dist: Ratnagiri and 1 Unit in Mahad, Dist: Raigad) with a total volumetric installed capacity of 4920 MTPA.

Peers
Company Name CMP
Godrej Industries 1043.95
SRF 2466.00
BASF India 3387.20
Pidilite Inds. 1499.00
Tata Chemicals 632.40
View more..